Latest collaboration video

Watch the video on our entrepreneurial collaboration with Cambridge Judge Business School. The ‘Accelerate Cambridge’ Life Sciences programme aims to identify, train and mentor early-stage life science ventures in Cambridge.

Read more about this collaboration


LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

AZ1566_Equipment_microscopescreen_THM 17 June 2015

Phase IIa trial results for AZD4901 support the potential for delivering a new treatment for women with Polycystic Ovary Syndrome

CRISPR Conference

We are pleased to announce the inaugural Sanger Institute-AstraZeneca conference centred on the application of CRISPR technology to the understanding and treatment of human disease. Read More

CRISPR Conference

Latest press releases

AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
27 July 2015
AstraZeneca provides update on selumetinib in uveal melanoma
22 July 2015
AstraZeneca completes agreement with Tillotts Pharma for Entocort
17 July 2015
AstraZeneca enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan
16 July 2015
IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
13 July 2015
AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort
9 July 2015
AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
16 June 2015
AstraZeneca reveals findings of archaeological dig as build gets underway at Cambridge Biomedical Campus
11 June 2015
New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin compared with sitagliptin
8 June 2015
AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformin for the treatment of type 2 diabetes
6 June 2015
AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the American Diabetes Association 75th Scientific Sessions
3 June 2015
AstraZeneca updates on immuno-oncology combinations development programme at ASCO 2015
2 June 2015